Executive officer

Miriam Provost, Ph.D.

Vice President of U.S. Regulatory and FDA Relations·TransMedics Group, Inc.

About

Dr. Miriam Provost has served as TransMedics' Vice President of U.S. Regulatory and FDA Relations since February 2018, after serving as a key regulatory consulting advisor to the company for over three years, and was a named executive officer in the 2021 and 2022 fiscal years.

She has over 23 years of experience in medical device regulatory affairs; prior to joining TransMedics she was a Senior Regulatory Consultant at the Biologics Consulting Group, Inc.

Earlier she spent 13 years as a reviewer and manager at the FDA across a variety of roles; she holds a Bachelor's degree in Chemical Engineering from the University of Dayton and M.S. and Ph.D. degrees in Chemical Engineering from the University of Pennsylvania.

Since February 2018
Age 58
Tenure 8 yrs

Also at TransMedics Group, Inc.

WM Waleed H. Hassanein, M.D. Founder, President and Chief Executive Officer; Director JT James R. Tobin Director; Chairperson of the Board EB Edward M. Basile Director; Chairperson of the Nominating and Corporate Governance Committee TG Thomas J. Gunderson Director; Chairperson of the Compensation Committee EJ Edwin M. Kania, Jr. Director SL Stephanie Lovell Director

Roles

Organization Role Dates Details
TransMedics Group, Inc. Vice President of U.S. Regulatory and FDA Relations February 2018–present Current role
Biologics Consulting Group, Inc. Senior Regulatory Consultant Provided strategic guidance and tactical support for large and small medical device companies.
U.S. Food and Drug Administration Reviewer and manager (variety of roles) Spent 13 years at the FDA.

Related

Company TransMedics Group, Inc. Company hub Person Waleed H. Hassanein, M.D. Founder, President and Chief Executive Officer; Director Person James R. Tobin Director; Chairperson of the Board Person Edward M. Basile Director; Chairperson of the Nominating and Corporate Governance Committee Person Thomas J. Gunderson Director; Chairperson of the Compensation Committee Person Edwin M. Kania, Jr. Director Person Stephanie Lovell Director Person Merilee Raines Director; Chairperson of the Audit Committee Person David Weill, M.D. Director Person Gerardo Hernandez Chief Financial Officer and Treasurer Person Giovanni Cecere Chief Commercial Officer Person Nicholas Corcoran Senior Vice President of Supply Chain and Operations Person Matthew Forsyth Senior Vice President, General Counsel and Corporate Secretary
Source: TransMedics Group, Inc. proxy statement (SEC Schedule 14A)

Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.

See how VectorShift works for your firm

Request Demo